Effective management of the bubonic plague requires a rapid, multi-modal approach centered on antibiotic therapy, supportive care, and strict infection control. Historically a devastating pandemic, Yersinia pestis remains treatable when clinicians maintain a high index of suspicion, particularly in endemic regions or after exposure to potential reservoirs. The cornerstone of modern treatment is the immediate initiation of broad-spectrum antibiotics, which dramatically reduce mortality rates from historic highs to less than 15 percent when administered promptly.
First-Line Antibiotic Regimens
The treatment of bubonic plague relies on several antibiotics that have proven efficacy against Yersinia pestis. Streptomycin and gentamicin remain the gold standard, typically administered for a minimum of 10 days or until three days after the fever subsides. In settings where injectable agents are unavailable, doxycycline or ciprofloxacin serve as suitable alternatives, providing reliable oral or intravenous options for initial stabilization.
Streptomycin and Gentamicin
These aminoglycosides are preferred due to their bactericidal action and historical success in resolving buboes and septicemia. Administered intramuscularly or intravenously, they require careful monitoring for ototoxicity and nephrotoxicity, especially in pediatric or geriatric populations. The standard course targets the rapid clearance of bacteria from the lymphatic and circulatory systems, preventing progression to septicemic or pneumonic stages.
Alternative Doxycycline and Ciprofloxacin
Doxycycline offers a practical alternative for mild to moderate cases, particularly in outpatient settings or for mass prophylaxis following exposure. Ciprofloxacin provides a broad spectrum of activity and is often utilized in bioterrorism scenarios due to its stability and ease of storage. Both alternatives support the principle of treating the infection systemically to avoid complications such as shock or organ failure.
Supportive and Adjunctive Care
Beyond antimicrobial agents, aggressive supportive care is essential for managing the systemic inflammatory response associated with severe plague. Fluid resuscitation addresses dehydration and hypotension, while vasopressors may be necessary to maintain adequate blood pressure. Respiratory support, including mechanical ventilation, is critical if the infection progresses to pneumonic plague or causes acute respiratory distress syndrome.
Management of the Buboe
The characteristic bubo requires careful local care to prevent secondary infection and facilitate drainage. While incision and drainage were historically common, modern practice favors conservative management with antibiotics to avoid creating draining sinuses. Pain control with analgesics and strict hygiene at the site help reduce discomfort and limit the risk of nosocomial transmission to healthcare workers.
Infection Control and Isolation Protocols
Because bubonic plague can evolve into pneumonic plague, stringent isolation precautions are mandatory from the point of diagnosis. Patients are placed in airborne infection isolation rooms, and healthcare personnel utilize N95 respirators or powered air-purifying respirators. Standard precautions are augmented by contact and droplet precautions to block transmission through respiratory droplets or direct contact with purulent material.
Public Health and Prophylaxis
Contact tracing and prophylactic antibiotics for exposed individuals are vital components of outbreak containment. Close contacts, including household members and healthcare providers, typically receive a seven to ten day course of doxycycline or ciprofloxacin. Public health authorities coordinate these interventions to interrupt transmission chains and prevent the sporadic cases from escalating into community-wide epidemics.
